Foot and Mouth Disease Vaccine Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 1.94 Bn

Forecast Year, 2035

USD 3.48 Bn

CAGR, 2026 - 2035

6.02%

Report Coverage

Global

What is the Foot and Mouth Disease Vaccine Market Size?

The global foot and mouth disease vaccine market size was valued at USD 1.94 billion in 2025, accounted for USD 2.05 billion in 2026, and is expected to reach around USD 3.48 billion by 2035, expanding at a CAGR of 6.02% from 2026 to 2035. Growing livestock population and increasing demand for animal products are some of the factors contributing to the increased adoption of these vaccines globally.

Foot And Mouth Disease Vaccine Market Key Takeaways

• In terms of revenue, the foot and mouth disease vaccine market is valued at USD 1.94 billion in 2025.
• It is projected to reach USD 3.48billion by 2035.
• The foot and mouth disease vaccine market is expected to grow at a CAGR of 6.02% from 2026 to 2035.
• Asia Pacific dominated the foot and mouth disease vaccine market in 2025 and is expected to maintain its position during the forecast period.
• Latin America is expected to witness significant growth during the forecast period.
• By vaccine type, the oil-based segment dominated the market in 2025.
• By vaccine type, the aluminum hydroxide and saponin vaccine segment is projected to experience the fastest growth during the forecast period.
• By animal type, in 2023, the cattle segment dominated the market.
• By animal type, the sheep and goats segment is projected to experience the fastest growth during the forecast period.
• By distribution channel, the government institutions segment dominated the market in 2025.
• By distribution channel, the veterinary clinics segment held a notable share in 2025 and is expected to grow considerably during the forest period.

Market Overview

Foot and mouth disease (FMD) is a highly contagious viral illness affecting livestock, including sheep, goats, swine, cattle, and other animals. It can cause severe economic losses and affects intensively reared animals more than traditional breeds. FMD results in fever and blister-like sores on the tongue, lips, mouth, teeth, and between the hooves. While most animals recover, the disease can lead to high mortality in young animals and production losses.

The virus responsible for foot and mouth disease belongs to the Picornaviridae family, and seven different strains are endemic in various countries worldwide. Each strain requires a specific vaccine to provide immunity to vaccinated animals. The foot and mouth disease virus (FMDV) has seven serotypes: O, A, C, SAT1, SAT2, SAT3, and Asia 1. Animals infected with this virus often show symptoms such as blisters on the lips and tongue, reduced meat and milk production, fever, excessive salivation, and loss of appetite. Various vaccines containing ingredients like aluminum hydroxide, saponin, and oil are used to protect animals from contracting FMD.

Market Trends

The increasing need for animal farming and the heavy expansion of dairy production have contributed to the industry's growth in the current period. Moreover, farmers have seen in raising more animals to meet the competing need for milk and meat in recent years. As animal farming practices have evolved, there is an urgent requirement for the maintenance of animal health in the upcoming years.

The increased focus on food safety is anticipated to increase industry growth in the coming period, as several governments are launching some vaccination programs for healthy animals, which benefits the products which is released by animals, such as eggs and milk. Moreover, the launch of innovative and safer vaccines is biggest opportunity for the manufacturers during the forecast period.

Foot And Mouth Disease Vaccine Market Growth Factors

• The high incidence of FMD, along with its major impact on foreign trade of animal products, is propelling the growth of the foot and mouth disease vaccine market.
• The rise in consumption of dairy products globally is also positively impacting the foot and mouth disease vaccine market.
• In the foot and mouth disease vaccine market, the increasing meat processing industry can further contribute to its expansion shortly.
• Increase in globalization along with the rising livestock population in developing markets are also fueling the market growth.
• The growing presence of veterinary centers to provide the best healthcare services for livestock can also boost the foot and mouth disease vaccine market in the projected period.

Market Scope

Market Dynamics

Drivers

The rise in the incidence of FMD

The growth of the foot and mouth disease vaccine market is fueled by several factors, including the rise in FMD outbreaks, increasing demand for animal products, and government efforts to control the disease. With the global population growing and the demand for meat and dairy products rising, the livestock industry is expanding, leading to a greater need for FMD vaccination to prevent and manage outbreaks.

Governments worldwide are also taking steps to prevent FMD outbreaks, further driving the demand for FMD vaccinations. Organizations like the International Organization for Animal Health (OIE) and the Food and Agriculture Organization of the United Nations (FAO) have established the Global FMD Control Strategy to address this issue.

• In March 2023, the government of India announced that around 24 crore cattle and buffaloes have been covered under Foot and Mouth Disease (FMD) vaccination drive. Out of a targeted population of 25.8 crore cattle, reaching a near-universal coverage of over 95 percent, which is well beyond the herd immunity level, an official statement said.

Restraint

An increase in vaccine failures

There have been reports of vaccine failures in preventing and treating FMD, which may hinder growth prospects, especially in developing countries. Alleged vaccine failures could also threaten animals in Europe and North America. A research study by the Indian Council of Agricultural Research found that vaccine samples from certain companies did not meet quality standards and failed in sterility tests. This suggests that recent FMD outbreaks in India may be due to poor vaccine quality, leading to significant economic losses. Such issues could negatively impact the foot and mouth disease vaccine market.

Opportunities

Increasing mergers and acquisitions

The foot and mouth disease vaccine market has witnessed increased mergers and acquisitions, which will likely drive market growth. Vendors are increasingly focusing on inorganic growth strategies to expand their presence and expertise in the market. In addition, such strategies will boost their growth and profitability in the market. These strategies will benefit new companies that aim to penetrate the market quickly. These are among the leading animal health companies in the world. The vendors are also forming collaborations to expand their reach in the market. Such initiatives will likely fuel market growth.

• In March 2024, Boehringer Ingelheim, a renowned player in the animal health sector, collaborated with Square Pharmaceuticals to launch Aftovaxpur in Bangladesh. This advanced foot-and-mouth disease (FMD) vaccine is specifically formulated for ruminants, including cattle and sheep, aiming to enhance regional livestock health.

Segment Insights

Vaccine Type Insights

The oil-based segment dominated the foot and mouth disease vaccine market in 2025. The conventional vaccines segment is leading due to the increasing use of oil-based vaccines, which offer longer-lasting effectiveness and higher efficacy. While other conventional vaccines effectively prevent diseases, they protect for a shorter time. This means that frequent vaccination is required for preventive measures.

• In December 2023, Dr. K. Anand Kumar, managing director of Indian Immunologicals Ltd., said that The Indian Immunological Institute, a subsidiary of the National Dairy Development Board (NDDB), is working on new vaccines to treat lumpy skin disease and infectious bovine rhinotracheitis (IBR) virus along with a combination of vaccines for protection against rabies.

The aluminum hydroxide and saponin vaccine segment is projected to experience the fastest growth during the forecast period. This is because these vaccines, containing aluminum hydroxide gel and saponin, along with oil adjuvants, are commonly used in inactivated FMD vaccines to manage the disease. On average, the expected lifespan of livestock, such as cattle, is between 18 and 22 years.

Animal Type Insights

The cattle segment dominated the foot and mouth disease vaccine market share in 2025. Cattle are a primary focus for foot and mouth disease vaccination because they are highly susceptible to the disease, and many countries rely heavily on cattle sales for their economy. As the demand for higher quality and safer meat increases, there is growing awareness of diseases in cows and their potential transmission to humans (zoonosis). These factors are expected to positively impact the market in the coming years.

• According to the Food and Agriculture Organization (FAO), there are over 1.4 billion cattle worldwide, with India, Brazil, and China having the largest populations.

The sheep and goats segment is projected to experience the fastest growth during the forecast period. Although these animals are less prone to foot and mouth disease than cattle and swine, they can still contract and spread the disease. The increasing demand for products like wool and meat from sheep and goats is driving the need for foot and mouth disease vaccinations in this segment.

Distribution Channel Insights

The government institutions segment dominated the foot and mouth disease vaccine market in 2025. This is due to the Governments around the world taking proactive measures to control and prevent foot and mouth disease outbreaks. They have introduced national vaccination programs that include regular immunization of animals and emergency vaccination during outbreaks. These initiatives have resulted in a considerable rise in demand for foot and mouth disease vaccines across all market segments.

The veterinary clinics segment held a notable share in 2024 and is expected to grow considerably during the forest period. Vaccination is acknowledged as an effective strategy to reduce the economic impacts of foot and mouth disease. By preventing and controlling the spread of the disease, vaccination is increasing awareness of its benefits.

Regional Insights

Asia Pacific dominated the foot and mouth disease vaccine market in 2025 and is expected to maintain its position during the forecast period. This is because of the rising cases of foot and mouth disease, especially in countries like China and India, which have large animal populations. The demand for vaccines against foot and mouth disease is increasing in these countries due to higher consumer demand for meat and dairy products and a greater focus on animal welfare. Furthermore, the presence of major vaccine manufacturers like MSD Animal Health and Zoetis in the region is anticipated to boost market growth in the Asia Pacific further.

Europe: Robust Disease Monitoring Systems and Government Pricing

Europe is implementing consistent animal health monitoring systems, harmonized veterinary vaccine requirements, and coordinated outbreak response systems. Government-funded contingency stockpiling systems and livestock movement controls between countries to help sustain demand for high-quality FMD vaccines used on most commercial farms.

Vaccination coverage is planned to continue for improvement through structured livestock health programs in Spain and an emphasis on meat production for export-related consumption. Additionally, the vaccine procurement process for certified FMD vaccines will benefit from further expansion in the dairy and swine sectors.

Latin America is expected to witness significant growth during the forecast period, mainly due to the development and standardization of diagnostic tests in the region. The increasing demand for animal care products and the growing livestock population are also major factors driving market growth. Governments in the region are taking initiatives to promote safe healthcare practices for livestock and optimize vaccine-based control programs. They are also raising awareness among the public about the importance of proper vaccination to combat foot and mouth disease.

• In August 2023, the agriculture ministry in Brazil announced that Sau Paolo would become Brazil's seventh state to be declared a non-vaccination foot and mouth disease-free zone.

Latin America: Increased Demand for Vaccines Due To Expanding Food Exports

Vaccines in Latin America are in demand as a result of a large number of cattle ranches, a large exportation of beef, and the implementation of regionally-based programs to eliminate disease outbreaks. Consistency of supplies of vaccines should be ensured through public vaccination programs and cooperation between the marketing and distribution of livestock and biologics companies.

Brazil has a very large population of cattle and an export focus on beef; it is continually enhancing its general vaccination programs. The procurement of FMD vaccines by various chains of national livestock health programs is planned to provide Brazil with a fairly consistent supply.

Middle East and Africa: Enhancing Biosecurity in Disease-Prone Areas

The countries in the Middle East and Africa are combating their continuing outbreaks of disease with government-funded vaccination programs, improving veterinary services, and forming international relationships to address animal health. Continued developments in the dairy industry and interest in the dairy sector are planned to lead to a consistency of vaccines being utilized by livestock owners.

South Africa's capability to monitor disease more effectively and the inspection of livestock movement between countries have been enhanced due to the increasing number of commercial farms in South Africa.

Value Chain Analysis of the Foot and Mouth Disease Vaccine Market

• R&D: Ongoing refinement of antigens through improved vaccine delivery methods minimizes the potential for outbreaks; ongoing evaluation and improvement of the match between vaccine strain and the virulence of circulating disease strains.
  Key Players: Boehringer Ingelheim, Merck Animal Health, and Zoetis.
• Clinical Trials and Regulatory Approvals: Multisite field trials in geographic areas where livestock is endemic, biosafety validation of vaccine production facilities, compliance with the World Organisation for Animal Health (OIE) and national veterinary authorities, and documentation of batch consistency and efficacy are conducted before exportation of the vaccine toward cattle and swine populations.
  Key Players: Elanco Animal Health, Ceva Santé Animale, and Indian Immunologicals Limited.
• Formulation and Final Dosage Preparation: Oil-adjuvant technologies used to formulate vaccines, cold-chain compatible containers used to ship and store vaccines, and large-scale blending of inactivated antigens used for each vaccine production across cattle and swine populations to enhance the stability and accuracy of dosing.
  Key Players: Biogenesis Bago, Brilliant Bio Pharma, and Hester Biosciences.

Foot And Mouth Disease Vaccine Market Companies

• Merck & Co., Inc.
• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Indian Immunologicals Limited
• Bayer AG
• Hester Biosciences Limited
• China Animal Husbandry Industry Co., Ltd.
• Brilliant Bio Pharma Limited
• Limor de Colombia S.A.

Segments Covered in the Report

By Type

• Conventional Vaccines
• Aluminum Hydroxide/Saponin-based Vaccines
• Oil-based Vaccines
• Emergency Vaccines

By Animal

• Cattle
• Sheep and Goat
• Pigs
• Others (Antelope, Deer, Bison, and Camelids)

By Distribution Channel

• Veterinary Clinics
• Government Institutions
• Other

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa